Dr. Abseer is a highly reputed internal medicine specialist and an excellent clinician working at the NMC Royal Medical Center Halwan. He is well known for his expertise in the treatment of acute and chronic conditions. He has a special interest in the treatment and management of chronic diseases, such as Diabetes, Hypertension, Thyroid disorders, Heart failure, Coronary artery diseases, Acute and chronic liver diseases, Acute and Chronic Kidney Diseases, Airway Diseases Like Asthma and COPD, Rheumatoid Arthritis, SLE, Other Autoimmune Disorders, Vasculitis, Infectious diseases, and Allergies. Dr. Abseer completed his MBBS in 2012 at Yenepoya Medical College under Rajiv Gandhi University of Health Sciences, Bangalore, India. He obtained his MD in Internal Medicine in 2017 from the AJ Institute of Medical Sciences and Research Center under the Rajiv Gandhi Institute of Medical Sciences, Bangalore. Dr. Abseer has vast experience in various aspects of the medical profession in India. He has worked as a specialist physician at Janardhan Hospital in Kerala from 2017 to 2019. He also worked as an Assistant Professor and Specialist Physician of Internal Medicine at Malabar Medical College, Kerala, from 2019 to 2022. He had been dealing efficiently with patients in outpatient and inpatient care, emergency, and critical care medicine. He is an active member of the Association of Physicians in India, Kerala Chapter. He has achieved certification in the Comprehensive Critical Care Campaign by the Critical Care Foundation of India in 2020. He has attended various international and national CME programmes. He presented a paper on “Rare presentation of adult-onset Still's disease with macrophage activation syndrome successfully treated with cyclosporine at the Society of Medical Scientists of India. He also presented a case of tropical endomyocardial fibrosis caused by roundworm infestation at the Calicut Forum of Internal Medicine in 2019. He also presented a talk on nocardiosis at the Osmosis Club, Malabar Medical College, Kerala, in 2022. Dr. Abseer published an original article on the long-term study of the effectiveness and safety of ivabradine versus metoprolol in heart rate, LVEF, and post-myocardial infarction patients in the International Journal of Pharmaceutical and Clinical Research in 2022.